BlueNalu has secured USD 60 million in funding to bolster its production of sustainable seafood alternatives, targeting growth in the rapidly expanding alternative protein market.
Information on the Target
BlueNalu is an innovative leader in the alternative protein sector, focused on creating cultivated seafood products deriving from natural cells. The company aims to address sustainability concerns linked with traditional fishing practices, particularly for premium fish species that are over-fished and heavily relied upon, such as Bluefin Tuna and Mahi Mahi. Since its inception in 2018, BlueNalu has been dedicated to ensuring the availability of eco-friendly seafood alternatives, which align with the growing global demand for sustainable food sources.
With a target market that includes approximately 3 billion people who depend on seafood for protein, BlueNalu’s contributions to food security are increasingly vital. The company's intent is not only to provide high-quality seafood alternatives but also to lessen the reliance on over-exploited ocean resources, ensuring that marine ecosystems can thrive.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The cell-cultured meat industry, particularly in the United States, is experiencing a significant transformation. Traditional protein sources are being increasingly scrutinized for their environmental impacts, leading to a rising dem
Similar Deals
S2G Investments → Bettani Foods
2025
David Protein → Epogee
2024
Longfellow Park Ventures, LLC → Puraclenz Holdings Inc.
2024
Ahimsa Foundation → Eat Just
2024
Rage Capital
invested in
BlueNalu
in 2023
in a Series A deal
Disclosed details
Transaction Size: $60M